Free Apps Clause Samples

The "Free Apps" clause defines the terms under which users can access and use applications provided at no cost. Typically, this clause clarifies that while the app is free to download and use, certain features or content may require payment, or the app may display advertisements. It may also specify any limitations on support or updates for free users. The core function of this clause is to set clear expectations about what is included in the free offering and to prevent misunderstandings regarding costs or available features.
Free Apps. Upon installation of the Service, you may choose to access and use certain other features and functionality offered by Conga separately under additional terms but at no additional cost. You may need to agree to additional terms to install and access those features and functionalities.
View SourceView Similar (10)
Free Apps. Upon installation of the Service, you may choose to access and use certain other features and functionality offered by Conga separately under additional terms but at no additional cost. You may need to agree to additional terms to install and access those features and functionalities. If You are purchasing subscriptions to Conga Sign services, as indicated on the applicable Conga Order Form, then the terms of this Service Schedule apply to those Conga Sign services. In this Service Schedule, the term “Service” refers only to Conga Sign service.
View Source
Free Apps. If an App is provided to a Subscriber at no charge (other than as a trial version), App Publisher hereby grants Domo a nonexclusive, worldwide, fully paid-up, perpetual, royalty-free license to freely reproduce, distribute, transmit, use, modify, build upon, or otherwise exploit the free App for any purpose, commercial or non-commercial.
View Source
Free Apps. Configero reserves the right to modify, suspend, or discontinue any Software provided to you free-of-charge (“Free Apps”) at any time with or without notice to you, and Configero will not be liable to you or any third party should it exercise such rights. Configero shall have no uptime, customer support, or technical support obligations with respect to Free Apps.
View Source
Free Apps. No Royalty is payable for Apps with a List Price of $0.00 (“freemium”, “freeware”, etc.), known as “Free Apps”. Free Apps distributed through the Program will require a payment to us of $1000/month while available from the Connexion Store promoted via the Program.
View Source

Related to Free Apps

  • COVID-19 Vaccine Passports Pursuant to Texas Health and Safety Code, Section 161.0085(c), Contractor certifies that it does not require its customers to provide any documentation certifying the customer’s COVID-19 vaccination or post-transmission recovery on entry to, to gain access to, or to receive service from the Contractor’s business. Contractor acknowledges that such a vaccine or recovery requirement would make Contractor ineligible for a state-funded contract.

  • Directory Listing and Directory Distribution 41 5. Voice Information Service Traffic 43 6. Intercept and Referral Announcements 44 7. Originating Line Number Screening (OLNS) 44 8. Operations Support Systems (OSS) Services 44 9. Poles, Ducts, Conduits and ▇▇▇▇▇▇-▇▇-▇▇▇ ▇▇ ▇▇. Telephone Numbers 51 11. Routing for Operator Services and Directory Assistance Traffic 51 12. Unauthorized Carrier Change Charges 52 13. Good Faith Performance 52 INTERCONNECTION ATTACHMENT. 53 1. General 53 2. Points of Interconnection and Trunk Types 53 3. Alternative Interconnection Arrangements 57 4. Initiating Interconnection 58 5. Transmission and Routing of Telephone Exchange Service Traffic 59

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Mobile Application If Red Hat offers products and services through applications available on your wireless or other mobile Device (such as a mobile phone) (the "Mobile Application Services"), these Mobile Application Services are governed by the applicable additional terms governing such Mobile Application Service. Red Hat does not charge for these Mobile Application Services unless otherwise provided in the applicable additional terms. However, your wireless carrier's standard messaging rates and other messaging, data and other rates and charges will apply to certain Mobile Application Services. You should check with your carrier to find out what plans your carrier offers and how much the plans cost. In addition, the use or availability of certain Mobile Application Services may be prohibited or restricted by your wireless carrier, and not all Mobile Application Services may work with all wireless carriers or Devices. Therefore, you should check with your wireless carrier to find out if the Mobile Application Services are available for your wireless Device, and what restrictions, if any, may be applicable to your use of such Mobile Application Services.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.